M&A

CSL Behring Buys Vitaeris, Picks Up Transplant Rejection Therapeutic
BioSpace
Mon, 06/8/20 - 11:44 pm
CSL Behring
M&A
Vitaeris
transplant rejection
AstraZeneca reportedly eyed a merger with Gilead. But does 'Gileaz' make sense?
Fierce Pharma
Mon, 06/8/20 - 10:33 am
M&A
Gilead Sciences
AstraZeneca
UCB buys epilepsy firm Engage Tx in $270m deal
PM Live
Mon, 06/8/20 - 10:30 am
UCB Pharma
epilepsy
M&A
Engage Therapeutics
drug-device combos
Staccato Alprazolam
AstraZeneca Approaches Gilead About Potential Merger
Bloomberg
Sun, 06/7/20 - 10:53 pm
AstraZeneca
Gilead Sciences
M&A
As it happened: A bidding war for an antibiotic maker in a market that has ravaged its peers
Endpoints
Fri, 06/5/20 - 11:01 am
antibiotics
M&A
Tetraphase
AcelRx
Melinta Therapeutics
La Jolla Pharmaceutical
Bristol's Celgene merger sees it bounce Jounce drug pact
Fierce Biotech
Fri, 06/5/20 - 10:43 am
Bristol-Myers Squibb
Celgene
Jounce Therapeutics
M&A
immuno-oncology
Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech
Xconomy
Tue, 06/2/20 - 11:09 pm
Chinook Therapeutics
Aduro BioTech
M&A
kidney disease
Will Johnson & Johnson Acquire Arrowhead Pharmaceuticals?
Motley Fool
Tue, 06/2/20 - 11:05 pm
JNJ
Arrowhead Pharmaceuticals
M&A
Gilead trumpets data with newly-bought magrolimab in blood cancers
Pharmaforum
Sun, 05/31/20 - 11:53 pm
Gilead Sciences
ASCO 2020
Forty Seven
magrolimab
M&A
MDS
Novavax Makes a $167 Million Purchase to Boost Its Coronavirus Vaccine Production Capacity
Motley Fool
Wed, 05/27/20 - 11:59 pm
Novavax
vaccines
drug manufacturing
M&A
COVID-19
Praha Vaccines
What Sanofi Might Buy With Its Regeneron Windfall
Barron's
Wed, 05/27/20 - 11:01 am
Sanofi
Regeneron
M&A
gene therapy
Ultragenyx
Bluebird Bio
PhII Alzheimer's data looming, Shionogi spending up to $500M on a buyout involving one of the toughest bets in biotech
Endpoints
Tue, 05/26/20 - 12:02 pm
Shionogi
Alzheimer's disease
Tetra Therapeutics
M&A
Roche beefs up diagnostic arm with another bet on faster, cheaper DNA sequencing
Endpoints
Fri, 05/22/20 - 10:56 am
Roche
Stratos Genomics
DNA
M&A
DNA sequencing
Obliterated by Alzheimer's failure, Neurotrope relinquishes its Nasdaq spot in reverse merger
Endpoints
Mon, 05/18/20 - 10:47 am
M&A
reverse merger
Neurotrope BioSciences
Metuchen
Petros
Merck pours $400M into flea drugs for Fido
Endpoints
Wed, 05/13/20 - 11:38 am
Merck
animal health
M&A
Sentinel
Takeda posts surprise profit a year after Shire mega-merger
Pharmaforum
Wed, 05/13/20 - 10:52 am
Japan
Takeda
Shire
M&A
earnings
What's Behind Mylan's Mixed Q1 Results
Motley Fool
Mon, 05/11/20 - 11:38 pm
Mylan
Pfizer
Upjohn
M&A
Viatris
earnings
Bristol Myers Squibb Offers bluebird bio a $200 Million Royalty Buyout
Motley Fool
Mon, 05/11/20 - 11:36 pm
Bristol-Myers Squibb
Celgene
M&A
Bluebird Bio
Stepping on BioMarin's turf, PTC Therapeutics picks up PKU drug for a song
Endpoints
Thu, 05/7/20 - 10:42 am
PTC Therapeutics
Censa Pharmaceuticals
PKU
M&A
AbbVie, Allergan score FTC approval for $63B merger with one final hurdle left to go
Fierce Pharma
Wed, 05/6/20 - 12:09 am
AbbVie
Allergan
M&A
FTC

Pages